auto_awesome
Want to know who else bid on this?
ProposalForge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Biotechnologies Aramis Inc.Amount
$40.0M
Program
SIF Stream 1 - R&DProvince
QCType
Contribution
Agreement Number
033-2024-2025-Q1-820045
Purpose
This project will advance the development of a plant-based influenza vaccine candidate and continue to grow and enhance its world-leading virus-like particle technology platform in Quebec, Canada. The project consists of restarting the acquired Medicago pilot facility The project’s work phase is scheduled to end on December 31, 2026.
Biotechnologies Aramis Inc. × Innovation, Science and Economic Development Canada
2 grants totalling $80.0M
SIF Stream 1 - R&D
21 grants totalling $599.7M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| General Fusion Inc. | $74.3M | SIF Stream 1 - R&D |
| Ross Video Limited | $49.0M | SIF Stream 1 - R&D |
| Moltex Energy Canada Inc. | $47.5M | SIF Stream 1 - R&D |
| BlackBerry Limited | $40.0M | SIF Stream 1 - R&D |
| CBN Nano Technologies Inc. (CBNNT) | $40.0M | SIF Stream 1 - R&D |